Global Oxygen Delivery Equipment Market Size By Type (Oxygen Masks, Nasal Cannulas), By Application (COPD, Asthma), By Region, And Segment Forecasts, 2023 to 2032

The Global Oxygen Delivery Equipment Market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.7 billion by 2031, growing at a CAGR of 8.0% during the forecast period from 2023 to 2031. The demand for oxygen delivery equipment is witnessing robust growth owing to the rising prevalence of chronic respiratory conditions such as COPD and asthma, the increasing geriatric population, and the heightened need for respiratory support systems, especially post-COVID-19. Technological advancements in portable oxygen concentrators and the integration of smart monitoring features are also contributing to market expansion.

Drivers:

Rising Incidence of Respiratory Disorders:

The increasing burden of diseases such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma is one of the primary drivers of the oxygen delivery equipment market. With over 250 million cases of COPD globally, the need for effective oxygen therapy continues to rise.

Growth in Home Healthcare Services:

The global shift towards home-based care for chronic patients has significantly accelerated the adoption of portable oxygen concentrators and other user-friendly oxygen delivery devices, making oxygen therapy more accessible and convenient.

Technological Advancements in Equipment:

Continuous innovations such as compact, lightweight devices with longer battery life, pulse dose delivery mechanisms, and integrated remote monitoring features are enhancing patient compliance and boosting product adoption.

Restraints:

High Cost of Advanced Devices:

Despite technological improvements, the high initial cost and maintenance expenses of advanced oxygen delivery systems may restrict their adoption, especially in low- and middle-income regions.

Lack of Reimbursement in Developing Countries:

Limited insurance coverage and inadequate reimbursement policies in certain countries pose a significant barrier to the widespread use of oxygen delivery equipment.

Opportunity:

Expansion in Emerging Markets:

Rapid healthcare infrastructure development, increasing awareness of chronic respiratory conditions, and rising disposable income in emerging economies such as India, China, and Brazil present lucrative growth opportunities.

Integration with Digital Health Platforms:

The integration of oxygen delivery devices with mobile applications and cloud platforms for real-time health monitoring offers a promising growth path, aligning with the trend towards personalized and remote healthcare.

Market by System Type Insights:

In 2023, the Portable Oxygen Concentrators segment held the largest market share due to their ease of use, mobility, and growing preference for at-home oxygen therapy. This segment is expected to remain dominant, driven by increasing demand from the elderly population and patients with long-term respiratory conditions. Meanwhile, the Liquid Oxygen Systems segment is gaining traction in hospital settings, particularly for patients requiring high-flow oxygen therapy.

Market by End-use Insights:

The Homecare Settings segment emerged as the dominant end-use in 2023, accounting for over 45% of the total market revenue. The preference for home oxygen therapy due to comfort, cost-effectiveness, and advances in user-friendly devices continues to drive this segment. Hospitals and Clinics remain essential contributors, especially in managing acute respiratory failure cases and post-operative care.

Market by Regional Insights:

North America led the global market in 2023, underpinned by a high prevalence of respiratory disorders, favorable reimbursement policies, and technological innovation. Asia-Pacific is projected to exhibit the fastest growth through 2031 due to increasing healthcare spending, government initiatives to improve respiratory care, and a growing patient population. Europe also remains a key market driven by aging demographics and robust healthcare infrastructure.

Competitive Scenario:

Prominent players in the global oxygen delivery equipment market include Philips Respironics, Invacare Corporation, ResMed Inc., Chart Industries, Drive DeVilbiss Healthcare, Medtronic plc, Inogen Inc., Nidek Medical Products Inc., Fisher & Paykel Healthcare, and Teleflex Incorporated. These companies are focusing on R&D, expanding product lines, and strategic collaborations to strengthen their market position.

Recent Developments:

In 2024, Inogen Inc. launched a new ultra-lightweight portable oxygen concentrator with integrated Bluetooth monitoring.

In 2023, Philips Respironics introduced its next-generation DreamStation with enhanced humidification and smart data tracking.

In 2022, Chart Industries expanded its oxygen therapy production capacity in response to global shortages during respiratory health crises.

Scope of Work – Global Oxygen Delivery Equipment Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.7 billion

CAGR (2023–2031) 8.0%

Market Segments By System Type (Portable Concentrators, Liquid Oxygen, Compressed Gas Systems); By End-use (Homecare Settings, Hospitals & Clinics)

Growth Drivers Rising respiratory disease burden, homecare preference, technological advancements